We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-6.5%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$239M
AUM Growth
-$14.3M
Cap. Flow
+$18M
Cap. Flow %
7.56%
Top 10 Hldgs %
75.03%
Holding
66
New
2
Increased
22
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$15.5M
2
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$2.43M
3
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$1.67M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$714K
5
AMLP icon
Alerian MLP ETF
AMLP
+$650K

Top Sells

Rank Stock Value
1
BMR
BIOMED REALTY TRUST INC
BMR
+$1.53M
2
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$944K
3
VGK icon
Vanguard FTSE Europe ETF
VGK
+$450K
4
VDE icon
Vanguard Energy ETF
VDE
+$377K
5
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$365K

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.84%
2 Healthcare 15.89%
3 Real Estate 0.44%
4 Financials 0.27%
5 Materials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLN icon
51
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$276K 0.12%
7,520
– –
ILMN icon
52
Illumina
ILMN
$32.6B
$273K 0.11%
1,731
– –
SQNM
53
DELISTED
SEQUENOM INC NEW
SQNM
$249K 0.1%
176,777
+300
+0.2% +$447
IWB icon
54
iShares Russell 1000 ETF
IWB
$49.1B
$246K 0.1%
+2,157
New +$233K
IVV icon
55
iShares Core S&P 500 ETF
IVV
$898B
$211K 0.09%
1,020
– –
EPP icon
56
iShares MSCI Pacific ex Japan ETF
EPP
$2.32B
$209K 0.09%
5,332
-476
-8% -$17.3K
RGLS
57
DELISTED
Regulus Therapeutics
RGLS
$198K 0.08%
238
– –
ASRT
58
DELISTED
Assertio
ASRT
$149K 0.06%
178
+11
+7% +$10.2K
BAC icon
59
Bank of America
BAC
$436B
$135K 0.06%
10,009
-156
-2% -$2.11K
HNGR
60
DELISTED
Hanger Inc.
HNGR
$135K 0.06%
20,836
– –
BIOC
61
DELISTED
Biocept, Inc.
BIOC
$49K 0.02%
1
– –
APTO
62
DELISTED
Aptose Biosciences, Inc.
APTO
$36K 0.02%
27
– –
SEEL
63
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
VGT icon
64
Vanguard Information Technology ETF
VGT
$147B
– –
-17,912
Closed -$242K
VV icon
65
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
– –
-10,095
Closed -$944K
BMR
66
DELISTED
BIOMED REALTY TRUST INC
BMR
– –
-64,584
Closed -$1.53M
1 2
3

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Callan Capital held 66 positions worth $239M, down 5.6% from $253M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Callan Capital deployed $18M of net new capital in Q1 2016, opening 2 new positions and adding to 22 existing holdings. Its largest new stake was Agios Pharmaceuticals: 7,000 shares worth $284K.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 70% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $450K trimmed.

  • Callan Capital's largest Q1 2016 buy was Agios Pharmaceuticals: 7,000 shares worth $284K.
  • Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q1 2016, an estimated $15.5M increase.
  • Callan Capital's biggest Q1 2016 reduction was Vanguard FTSE Europe ETF, cutting an estimated $450K.
  • Callan Capital fully exited BIOMED REALTY TRUST INC in Q1 2016, selling an estimated $1.53M.
  • Callan Capital's ten largest holdings make up 75% of its $239M portfolio in Q1 2016.
  • Callan Capital opened 2 new positions and closed 3 in Q1 2016.
  • Callan Capital's portfolio value fell 5.6% quarter-over-quarter to $239M.

Based on Callan Capital's 13F filing for Q1 2016, filed 11 May 2016.